Mersana Therapeutics Provides Business Update and Announces First Quarter 2022 Financial Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Boston ,Massachusetts ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,American ,Mersana Dolasynthen ,Jason Fredette ,Upifitamab Rilsodotin Upri ,Anna Protopapas ,Exchange Commission ,American Association For Cancer Research ,Janssen Biotech Inc ,Society Of Gynecologic Oncology ,Mersana Therapeutics Inc ,Nasdaq ,Boston Globe ,Advanced Upri ,Chief Executive Officer ,Recent Developments ,Foundational Medicine ,Ovarian Cancer ,Gynecologic Oncology ,Annual Meeting ,Complete Enrollment ,Toward Initiation ,Patient Screening ,Gout Pipeline ,Highly Impactful Cancer Medicines ,Initiate Phase ,American Association ,Cancer Research ,Pipeline Prioritization Discipline ,Strategic Partners ,New Collaboration ,Janssen Biotech ,Private Securities Litigation Reform Act ,Annual Report ,Consolidated Statement ,Business ,Health ,Globe Newswire ,Cancer ,Clinical Trials ,